GlassScriptPhysician profile
Paul Douglas Becherer
NPI 1780772053
$2,033.16
in general payments reported to CMS, 2019-2025
15 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $66.88 · 2021: $215 · 2022: $379 · 2023: $458 · 2024: $428 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $556.49 | 2022-2025 | Infuse |
| Coopervision INC. | $305.12 | 2023-2025 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $238.58 | 2022-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $168.33 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $135.28 | 2020-2021 | |
| Amgen INC. | $124.69 | 2024 | Tepezza |
| Abbvie INC. | $112.17 | 2024 | |
| Allergan, INC. | $92.63 | 2020-2022 | |
| Ivantis, INC | $75.00 | 2021 | |
| Biotissue Holdings INC. | $66.42 | 2022 | |
| Shire North American Group INC | $52.22 | 2019 | |
| Alcon Vision LLC | $36.25 | 2023 | Precision 1, Total30 |
| Oyster Point Pharma, INC. | $30.97 | 2022 | |
| Glaukos Corporation | $20.74 | 2023 | Iaccess Precision Blade, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Photrexa Cross-Linking Kit |
| Sun Pharmaceutical Industries INC. | $18.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Becherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.